INNOGENE Co.,Ltd. (KOSDAQ:344860)
1,571.00
-10.00 (-0.63%)
At close: Apr 29, 2026
INNOGENE Revenue
In the year 2025, INNOGENE had annual revenue of 8.21B KRW, down -8.17%. INNOGENE had revenue of 2.41B in the quarter ending December 31, 2025, with 17.50% growth.
Revenue
8.21B
Revenue Growth
-8.17%
P/S Ratio
2.30
Revenue / Employee
n/a
Employees
n/a
Market Cap
18.90B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medience | 48.77B |
| Nord Mason | 21.26B |
| Ha U Dong Chun | 1.89B |
| KMPHARMACEUTICAL | 15.99B |
| Csa Cosmic | 27.93B |
| Outin Futures | 42.39B |
| SR biotek | 1.62B |
| Bonne | 46.01B |